Neeraj Agarwal, MD of the Huntsman Cancer Institute presents “Molecular predictors of response and survival outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with VEGF-TKIs” at the 14th International Kidney Cancer Symposium.